Cargando…
Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice
The purpose of the study is to evaluate the tumour enhancing characteristics and biodistribution of a newly developed metalloporphyrin derivative, HOP-9P (13, 17-bis (1-carboxypropionyl) carbamoylethyl-3, 8-bis (1-phenylpropyloxyethyl)-2,7,12,18-tetra- methyl-porphynato manganese (III)). Seven mice...
Autores principales: | Takehara, Y, Sakahara, H, Masunaga, H, Isogai, S, Kodaira, N, Takeda, H, Saga, T, Nakajima, S, Sakata, I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363677/ https://www.ncbi.nlm.nih.gov/pubmed/11401324 http://dx.doi.org/10.1054/bjoc.2001.1802 |
Ejemplares similares
-
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma
por: Cho, M, et al.
Publicado: (2001) -
Porphyrins and Metalloporphyrins
por: Wang, Jui H.
Publicado: (1964) -
Metalloporphyrins – An Update
por: Schulz, Stephanie, et al.
Publicado: (2012) -
A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment
por: Nakamoto, Y, et al.
Publicado: (1999) -
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
por: Uemura, H, et al.
Publicado: (1999)